Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 82.82B | 84.68B | 86.15B | 79.18B | 64.22B | 44.65B |
Gross Profit | 54.68B | 56.77B | 59.28B | 54.20B | 43.86B | 28.78B |
EBITDA | 23.82B | 23.44B | 25.14B | 23.22B | 19.15B | 10.14B |
Net Income | 4.56B | 5.21B | 6.30B | 5.80B | 4.95B | 1.93B |
Balance Sheet | ||||||
Total Assets | 138.72B | 146.34B | 140.87B | 131.95B | 122.36B | 106.02B |
Cash, Cash Equivalents and Short-Term Investments | 12.51B | 13.77B | 11.48B | 11.23B | 10.67B | 21.11B |
Total Debt | 39.18B | 40.79B | 38.46B | 35.16B | 34.47B | 37.85B |
Total Liabilities | 74.30B | 79.49B | 80.58B | 77.64B | 75.99B | 69.77B |
Stockholders Equity | 23.58B | 24.29B | 21.53B | 6.16B | 15.37B | 11.27B |
Cash Flow | ||||||
Free Cash Flow | 14.87B | 13.39B | 10.59B | 12.86B | 15.39B | 8.42B |
Operating Cash Flow | 19.52B | 18.92B | 18.40B | 17.83B | 18.65B | 10.88B |
Investing Cash Flow | -7.35B | -6.54B | -8.31B | -5.92B | -17.11B | -3.11B |
Financing Cash Flow | -10.93B | -10.73B | -9.54B | -12.49B | -14.32B | 7.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €269.95B | 25.13 | 16.88% | 2.32% | -3.24% | -21.24% | |
80 Outperform | $220.59B | 50.56 | 27.36% | 1.23% | 10.31% | 0.54% | |
76 Outperform | €91.47B | 20.75 | 19.54% | 2.47% | -3.24% | -21.65% | |
76 Outperform | €35.84B | 49.17 | 4.91% | 1.94% | -14.56% | -64.91% | |
75 Outperform | €2.37B | 17.12 | 20.31% | 3.22% | 9.68% | 19.46% | |
72 Outperform | €127.54B | 54.20 | 6.19% | 1.43% | 5.45% | 2.86% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |